Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection.
van Paassen PM, van Pul L, van der Straten K, Buchholtz NVJE, Grobben M, van Nuenen AC, van Dort KA, Boeser-Nunnink BD, van den Essenburg MD, Burger JA, van Luin M, Jurriaans S, Sanders RW, Swelsen WT, Symons J, Klouwens MJ, Nijhuis M, van Gils MJ, Prins JM, de Bree GJ, Kootstra NA. van Paassen PM, et al. Among authors: van pul l. AIDS. 2023 Dec 1;37(15):2297-2304. doi: 10.1097/QAD.0000000000003722. Epub 2023 Sep 11. AIDS. 2023. PMID: 37702421 Free PMC article.
Identification of 2-(4-N,N-Dimethylaminophenyl)-5-methyl-1-phenethyl-1H-benzimidazole targeting HIV-1 CA capsid protein and inhibiting HIV-1 replication in cellulo.
Alvarez G, van Pul L, Robert X, Artía Z, van Nuenen AC, Long M, Sierra N, Porcal W, Kootstra NA, Guillon C. Alvarez G, et al. Among authors: van pul l. BMC Pharmacol Toxicol. 2022 Jun 28;23(1):43. doi: 10.1186/s40360-022-00581-7. BMC Pharmacol Toxicol. 2022. PMID: 35765101 Free PMC article.
A Robust SARS-CoV-2-specific T and B Cell Response is Associated with Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.
Vergouwe M, Biemond JJ, van der Straten K, van Pul L, Kerster G, Claireaux M, Burger JA, van Dort KA, Kootstra NA, Jonges M, Welkers MRA, Hazenberg MD, Peters-Sengers H, van Gils MJ, Wiersinga WJ, Birnie E, de Bree GJ; TURN-COVID study group. Vergouwe M, et al. Among authors: van pul l. J Infect Dis. 2024 Jun 6:jiae306. doi: 10.1093/infdis/jiae306. Online ahead of print. J Infect Dis. 2024. PMID: 38843052
Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.
Verburgh ML, van Pul L, Grobben M, Boyd A, Wit FWNM, van Nuenen AC, van Dort KA, Tejjani K, van Rijswijk J, Bakker M, van der Hoek L, Schim van der Loeff MF, van der Valk M, van Gils MJ, Kootstra NA, Reiss P. Verburgh ML, et al. Among authors: van pul l. Microbiol Spectr. 2023 Jun 15;11(3):e0115523. doi: 10.1128/spectrum.01155-23. Epub 2023 May 11. Microbiol Spectr. 2023. PMID: 37166335 Free PMC article.